Misonix has signed a new, three year, exclusive distribution agreement with privately-held Intermedica of Nizhny Novgorod, Russia for the distribution of the Sonablate 500 high intensity focused ultrasound system.
Subscribe to our email newsletter
The agreement provides Intermedica with the rights to sell in Russia, Belarussia, Kazakstan and the Ukraine, and includes minimum purchase requirements.
The Sonablate SB500, a high intensity focused ultrasound-based, image-guided, acoustic ablation system is developed by Focus Surgery.
Michael McManus, Jr, president and CEO of Misonix, said: “By building relationships with highly regarded clinical opinion leaders, who function as reference sites, Intermedica has demonstrated their ability to effectively educate their markets to the benefits of new and exciting technologies.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.